Day: January 6, 2023

Plano, Texas, Jan. 05, 2023 (GLOBE NEWSWIRE) — Broad Capital Acquisition Corp (the “Company”) (Nasdaq: BRAC/BRACU/BRACR), a special purpose acquisition company, today announced that it has postponed the Special Meeting of Shareholders scheduled to occur on January 9, 2023 (the “Special Meeting”) until January 10, 2023 at 10:30 am at the same location as set forth in the Proxy Statement. On December 28, 2022, the Company filed a Definitive Proxy Statement on Schedule 14A (the “Proxy Statement”) with the Securities and Exchange Commission (the “SEC”) with respect to the Special Meeting to vote on, among other things, a proposal to amend the Company’s Amended and Restated Certificate of Incorporation (the “Charter”) to extend the date by which the Company must consummate a business combination (the “Extension”) from January 13, 2022...

TORONTO, Jan. 05, 2023 (GLOBE NEWSWIRE) — Celestica’s third quarter financial results and conference call will take place on Thursday, January 26. The conference call start time is 8:00am ET. Financial results will be released after market close on Wednesday, January 25. Participants are invited to join the live webcast at: https://viavid.webcasts.com/starthere.jsp?ei=1592033&tp_key=456f273f42 For those unable to participate, a recorded webcast will be available approximately two hours after completion of the call. To access the recorded webcast visit www.celestica.com. Contact Celestica Investor Relations(416) 448-2211clsir@celestica.com

Multi-year collaboration focuses on three strategic pillars: cancer immunotherapies, infectious disease vaccines, and expansion of BioNTech’s footprint in the UK BioNTech aims to design and roll out randomized clinical trials with registrational potential for the Company’s personalized mRNA cancer immunotherapies in the UK Accelerated clinical trial recruitment with first patient to be enrolled in a trial as part of this collaboration in H2 2023 Set-up of an R&D hub in Cambridge (UK) with the aim to employ more than 70 highly skilled scientists with the first employees commencing work in Q1 2023MAINZ, Germany, January 6, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech”, “the Company”) today announced that the Company signed a Memorandum of Understanding (“MoU”) with the Government of the United Kingdom (“UK”) to benefit patients by...

LISLE, Ill., Jan. 05, 2023 (GLOBE NEWSWIRE) — CTS Corporation (NYSE: CTS) announced today that Kieran O’Sullivan, President and Chief Executive Officer, will be participating at the 25th Annual Needham Growth Conference on January 10, 2023, at 3:45 p.m. (EDT) in New York City. You may access a live webcast of the event using this link or from the Investors section of the CTS Corporation website at www.ctscorp.com. The webcast will also be available for replay on this website for 90 days following the presentation. About CTS CTS (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors, electronic components, and actuators in North America, Europe, and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical, and transportation...